About Lichen Health
Marie Pierre Chevalier
FOUNDER & CEO
Physician by training, Marie-Pierre Chevalier has more than 20 years of experience in major international pharmaceutical groups in various positions in clinical development, business development, KOLs management in different therapeutic areas such as oncology, rare diseases, neurodegenerative diseases, chronic inflammatory diseases, etc.
For the last 10 years, she has successfully led the open-innovation entity of Pfizer France, achieving numerous collaborations between the group’s global R&D and academic or Biotechs teams. More recently, she initiated the digital transformation of the organization.
Involved in the health innovation ecosystem, she has served on several life science investment funds such as the InnoBio Fund or Patient Autonome Fund. She also seated in the Selection Committee of the Brain Institute ‘s Incubator iPEPs based in the Pitié-Salpétrière Hospital in Paris.
Lichen Health Genesis
«The lichen is the company’s promise:
Growing startups in symbiosis with their environment»
Lichen Health is the synthesis between two of my interests, medicine and nature preservation. I chose the lichen to embody my society because it is a symbiosis between an algae and a fungus.
This symbiosis is at the heart of my project to grow health innovation projects in symbiosis with their environment.
Lichen is also a biomarker of forest health and air quality. Finally, from a more personal point of view, the lichen is a strong image of my childhood spent in the heart of the forests in Auvergne.